These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16134134)

  • 1. Long-term survival with non-proportional hazards: results from the Dutch Gastric Cancer Trial.
    Putter H; Sasako M; Hartgrink HH; van de Velde CJ; van Houwelingen JC
    Stat Med; 2005 Sep; 24(18):2807-21. PubMed ID: 16134134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
    J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control.
    Krijnen P; den Dulk M; Meershoek-Klein Kranenbarg E; Jansen-Landheer ML; van de Velde CJ
    Eur J Surg Oncol; 2009 Jul; 35(7):715-20. PubMed ID: 19144490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?
    Park SS; Park JM; Kim JH; Kim WB; Lee J; Kim SJ; Kim CS; Mok YJ
    J Surg Oncol; 2006 Jul; 94(1):16-20. PubMed ID: 16788938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer.
    Hartgrink HH; van de Velde CJ
    J Surg Oncol; 2005 Jun; 90(3):153-65. PubMed ID: 15895448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
    Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended lymph node dissection in gastric carcinoma: should we change our policy after the long-term results of dutch randomized trial?
    Biffi R; Fazio N; Chiappa A; Luca F; Pace U; Cenciarelli S; Pozzi S; Andreoni B
    Hepatogastroenterology; 2006; 53(69):2p preceding I. PubMed ID: 16795962
    [No Abstract]   [Full Text] [Related]  

  • 9. A method for sequential analysis of survival data with nonproportional hazards.
    Sooriyarachchi MR; Whitehead J
    Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
    Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
    Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended lymph-node dissection in gastric cancer: standard, selective or unnecessary procedure?
    Roukos D; Paraschou P
    Hepatogastroenterology; 2000; 47(33):904-6. PubMed ID: 10919059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim analysis on survival data: its potential bias and how to repair it.
    van Houwelingen HC; van de Velde CJ; Stijnen T
    Stat Med; 2005 Sep; 24(18):2823-35. PubMed ID: 16025546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
    Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
    Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.
    Weight CJ; Reuther AM; Gunn PW; Zippe CR; Dhar NB; Klein EA
    Urology; 2008 Jan; 71(1):141-5. PubMed ID: 18242383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.